. Author manuscript; available in PMC: 2026 Jun 18.

Published in final edited form as: Patient Educ Couns. 2025 Oct 8;142:109382. doi: 10.1016/j.pec.2025.109382

Table 4:

Bivariable associations of HCP-related facilitators, race, and BRCA mutation with risk-management outcomes.

	Screening Concordance^μ			Awareness of Risk-Reduction Options⁺
	CBE	Mammogram	MRI	Mastectomy	Oophorectomy	Chemoprevention
PPR with PCP/WHP > 5yrs^ю	2.17^*** (1.55, 3.02)	2.51^*** (1.61, 3.91)	1.38 (.931, 2.05)	1.15 (.766, 1.73)	1.48^* (1.09, 2.02)	1.94^*** (1.43, 2.63)
Risk Discussion with PCP/WH^∞	4.50^*** (2.98, 6.80)	2.87^** (1.38, 5.95)	6.42^*** (2.26, 18.2)	1.84^* (1.15, 2.95)	2.56^*** (1.73, 3.78)	4.68^*** (2.80, 7.83)
Seen a specialist^α	3.47^*** (2.45, 4.92)	3.99^*** (2.53, 6.29)	13.4^*** (7.28, 24.66)	1.88^** (1.23, 2.86)	4.14^*** (2.97, 5.79)	7.51^*** (5.33, 10.57)
Race^±	.580^**	.366^***	.277^***	.396^**	.380^***	.375^***
	(.417,.807)	(.233,.574)	(.172,.447)	(.263,.594)	(.276,.523)	(.267,.527)
Known BRCA mutation^¥	7.38^***	4.87^***	17.0^***	1.25	7.07^***	8.62^***
	(3.89, 14.0)	(2.61, 9.08)	(10.4, 27.7)	(.740, 2.10)	(4.04, 12.4)	(5.60, 13.3)

Results are odds ratios (95 %-confidence intervals in parentheses). Example interpretation: Black women were just over half as likely as White women to report having had CBE.

p < 0.05.

^**

p < 0.01.

^***

p < 0.001.

^ю

Participants indicated how long their longest relationship was with a PCP/WHP; 0 = ”≤ 5 years”, 1”> 5 years”.

^∞

Participants indicated whether they had ever discussed BC risk; 0 = ”Never”, 1 = ”A little” or “A lot”.

^α

Participants indicated whether they had ever seen a specialist about their BC risk; 0 = ”Never”, 1 = ”At least once”.

^μ

Participants who were recommended a given screening modality by NCCN guidelines according to their personalized risk score indicated whether they had undergone a given screening modality in the last year; 0 = ”No”, 1 = ”Yes”.

⁺

Participants were given definitions of risk-reduction options high-risk women are recommended to be aware of by the NCCN and indicated whether they had ever heard of the option; 0 = ”No”, 1 = ”Yes”.

^±

Participants indicated whether they were non-Hispanic Black or non-Hispanic white= ; 0 = ”Non-Hispanic white”, 1 = ”Non-Hispanic Black”.

^¥

Participants indicated whether they had ever received genetic testing and learned they had a BRCA mutation; 0 = ”No”, 1 = ”Yes”.